Clinical Trial

Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue

Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, multicenter, randomized, evaluator-blinded, parallel-controlled, non-inferiority clinical study designed to evaluate the safety and effectiveness of the ULTRAFORMER MPT PLUS, a high-intensity focused ultrasound (HIFU) device, for lifting and tightening lax submental (beneath the chin) and neck tissue in adult subjects. Approximately 273 subjects will be enrolled at multiple investigational sites across the United States. Participants will receive either the ULTRAFORMER MPT PLUS treatment or the predicate comparator device, and will be followed for safety and efficacy assessments including clinical photography, investigator evaluation, and patient-reported outcomes. The study aims to demonstrate that ULTRAFORMER MPT PLUS is non-inferior to the approved reference device in improving skin laxity and wrinkle appearance of the lower face and neck.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-11-13; most recent amendment 2026-04-16.
Trial Details
NCT Number NCT07229430
Lead Sponsor CLASSYS Inc.
Conditions Skin Laxity (Submental and Neck), Facial Skin Laxity, Submental Tissue Laxity
Enrollment 273 participants
Start Date 2025-10-16
Primary Completion 2026-11-26 (estimated)
Study Completion 2026-11-26 (estimated)
Updated on ClinicalTrials.gov 2026-04-20